
### [NCIT:C8402](http://purl.obolibrary.org/obo/NCIT_C8402)
**Label:** Fibrohistiocytic Neoplasm

**Subclasses:** [NCIT:C6801](http://purl.obolibrary.org/obo/NCIT_C6801) (Cutaneous Fibrous Histiocytoma), [NCIT:C53963](http://purl.obolibrary.org/obo/NCIT_C53963) (Benign Fibrous Histiocytoma of Bone), [NCIT:C49078](http://purl.obolibrary.org/obo/NCIT_C49078) (Cutaneous Fibrous Histiocytoma, Cellular Variant), [NCIT:C121929](http://purl.obolibrary.org/obo/NCIT_C121929) (Non-Ossifying Fibroma), [NCIT:C7749](http://purl.obolibrary.org/obo/NCIT_C7749) (Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C49076](http://purl.obolibrary.org/obo/NCIT_C49076) (Cutaneous Fibrous Histiocytoma, Fibroblastic Variant), [NCIT:C6535](http://purl.obolibrary.org/obo/NCIT_C6535) (Malignant Tenosynovial Giant Cell Tumor), [NCIT:C49107](http://purl.obolibrary.org/obo/NCIT_C49107) (Giant Cell Tumor of Soft Tissue), [NCIT:C7344](http://purl.obolibrary.org/obo/NCIT_C7344) (Intermediate Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C7343](http://purl.obolibrary.org/obo/NCIT_C7343) (Benign Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C6532](http://purl.obolibrary.org/obo/NCIT_C6532) (Tenosynovial Giant Cell Tumor, Localized Type), [NCIT:C6492](http://purl.obolibrary.org/obo/NCIT_C6492) (Deep Benign Fibrous Histiocytoma), [NCIT:C6491](http://purl.obolibrary.org/obo/NCIT_C6491) (Intermediate Fibrohistiocytic Neoplasm), [NCIT:C6490](http://purl.obolibrary.org/obo/NCIT_C6490) (Benign Fibrohistiocytic Neoplasm), [NCIT:C129549](http://purl.obolibrary.org/obo/NCIT_C129549) (Intracranial Benign Fibrous Histiocytoma), [NCIT:C121500](http://purl.obolibrary.org/obo/NCIT_C121500) (Malignant Fibrohistiocytic Neoplasm), [NCIT:C35765](http://purl.obolibrary.org/obo/NCIT_C35765) (Histiocytoma), [NCIT:C3739](http://purl.obolibrary.org/obo/NCIT_C3739) (Benign Fibrous Histiocytoma), 

**Class expressions from DL-Learner:**

- Thing 53.94%
- [NCIT:C36843](http://purl.obolibrary.org/obo/NCIT_C36843) (Abnormal Connective and Soft Tissue Cell) 42.01%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 40.81%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 38.69%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 38.69%


